Analyzing Acurx Pharmaceuticals' Q4 2023 Earnings Report
Monday, 18 March 2024, 15:15
Acurx Pharmaceuticals Q4 2023 Earnings Report
Acurx Pharmaceuticals recently announced its financial results for the fourth quarter of 2023, revealing a net loss of $0.37 per share. The company's cash balance declined to $7.5 million, reflecting the financial performance and challenges faced by the pharmaceutical entity.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.